Explore the latest books of this year!
Bookbot

Günter Müller-Stewens

    January 1, 1951
    Strategisches Management
    Corporate Strategy
    Lipases and phospholipases in drug development
    The Professionalization of Humanitarian Organizations
    Radical Business Model Transformation
    The New Strategist
    • 2020
    • 2020

      The New Strategist

      Shape Your Organization and Stay Ahead of Change

      • 336 pages
      • 12 hours of reading

      This practical guide offers insights for professionals aiming to excel as strategists by equipping them with the skills to adapt to evolving challenges. Grounded in original research, it provides actionable strategies and frameworks to enhance strategic thinking and decision-making in dynamic environments. Ideal for those seeking to navigate complex professional landscapes, the book emphasizes adaptability and innovative approaches to problem-solving.

      The New Strategist
    • 2018

      The Professionalization of Humanitarian Organizations

      The Art of Balancing Multiple Stakeholder Interests at the ICRC

      • 104 pages
      • 4 hours of reading

      This book offers deep insights into the functioning of humanitarian organizations (HOs) from a managerial perspective. Presenting an in-depth case study on the International Committee of the Red Cross (ICRC), it demonstrates how HOs can professionalize the management of their operations by adapting the institutional logic of private corporations and applying their tools and frameworks in the context of a non-profit-organization. The authors discuss the advantages of effective stakeholder and change management for HOs, as well as the tensions caused by conflicting institutional logics and ethical conflicts that arise as a result of a violation of the principles of an HO. The book appeals to anyone interested in managing non-governmental organizations more effectively.

      The Professionalization of Humanitarian Organizations
    • 2004

      Lipases and Phospholipases are key control elements in mammalian metabolism. They share many common features that set them apart from other metabolic enzyme classes, most importantly their association with biological membranes. Their potential as drug targets for the treatment of metabolic diseases is widely recognized, and the first lipase inhibitor drugs have been successfully introduced. Providing drug developers with a firm foundation for lipase-centered drug design, the editors of this volume have assembled experts from different scientific disciplines to create a comprehensive handbook for all pharmaceutical chemists, biochemists and physiologists working with lipases. The authors examine fundamental aspects of lipase function in vitro and in vivo, explaining how this knowledge may be used to develop lipase assays. They also treat the physiological roles of lipases in normal and disordered metabolism, as well as strategies to target lipases for the treatment of diabetes, obesity and related disorders. Additional topics include the application of phospholipases for liposome-based drug delivery and their use as diagnostic tools.

      Lipases and phospholipases in drug development